News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Sara Faithfull: Wonderful to meet up with amazing colleagues at MASCC Lille
Photo taken fro Sara Faithfull/X
Jul 4, 2024, 04:28

Sara Faithfull: Wonderful to meet up with amazing colleagues at MASCC Lille

Sara Faithfull, Professor at University of Surrey, shared on X:

“Wonderful to meet up with amazing UK colleagues at MASCC Lille. Both are passionate about radiotherapy late-effects and improving care for people living with and beyond a cancer diagnosis.”

Source: Sara Faithfull/X

cancer MASCC OncoDaily Oncology radiotherapy Sara Faithfull
Special Coverage
Blog
Apr 19, 2025, 17:53
Cancer Nutrition Tips: Pink Africa Foundation Highlights Healing Benefits
Blog
Apr 19, 2025, 17:21
Exploring the integration of patient-reported outcome measures in clinical practice
Blog
Apr 19, 2025, 17:17
Join our Networks and Working Groups to learn, network and grow - SIOP
Blog
Apr 19, 2025, 17:14
Re-irradiation revolution: Maximising technical advances in imaging, biology and dose evaluation at ESTRO 2025
Blog
Apr 19, 2025, 17:02
New whitepaper on navigation services and reimbursement success - Florida Cancer Specialists and Research Institute
Blog
Apr 19, 2025, 17:01
Chiara Mercinelli: Honored to have been selected for the ASCO 2025 Merit Award
Blog
Apr 19, 2025, 16:48
How EveryGrant helps organizations build impactful grant programs - Conquer Cancer, the ASCO Foundation
Blog
Apr 19, 2025, 16:44
Agenus to Reveal Phase 1 HCC Immunotherapy Data at AACR 2025
Blog
Apr 19, 2025, 16:36
Bilal Awad: Knowledge, attitudes, and self-efficacy regarding palliative care among Palestinian nurses in intensive care units
Blog
Apr 19, 2025, 16:23
Toufic Kachaamy: Thrilled to give two talks on cancer ablation at DDW2025
Blog
Apr 19, 2025, 16:23
Elvina Almuradova: Olaparib improved ORR and PFS in BRCA-mutated PSR ovarian cancer, but no OS benefit
Blog
Apr 19, 2025, 16:12
Cristian Massacesi: Visiting our AstraZeneca team in Germany to talk oncology ambitions